Shari Fallet

1.1k total citations
18 papers, 739 citations indexed

About

Shari Fallet is a scholar working on Molecular Biology, Physiology and Cell Biology. According to data from OpenAlex, Shari Fallet has authored 18 papers receiving a total of 739 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 9 papers in Physiology and 6 papers in Cell Biology. Recurrent topics in Shari Fallet's work include Amyloidosis: Diagnosis, Treatment, Outcomes (6 papers), Lysosomal Storage Disorders Research (5 papers) and Cellular transport and secretion (4 papers). Shari Fallet is often cited by papers focused on Amyloidosis: Diagnosis, Treatment, Outcomes (6 papers), Lysosomal Storage Disorders Research (5 papers) and Cellular transport and secretion (4 papers). Shari Fallet collaborates with scholars based in United States, Brazil and Germany. Shari Fallet's co-authors include Dennis R. Johnson, Pamela Arn, Robert J. Gorlin, John E Fantasia, Sonja Levanat, Hartmut Schmidt, Leslie Amass, Marc Botteman, Márcia Waddington‐Cruz and Markay Hopps and has published in prestigious journals such as Nature Genetics, Muscle & Nerve and Pediatric Research.

In The Last Decade

Shari Fallet

18 papers receiving 719 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shari Fallet United States 12 389 322 179 155 112 18 739
K D MacDermot United Kingdom 15 287 0.7× 627 1.9× 215 1.2× 290 1.9× 241 2.2× 27 1.1k
Jason S. Weisstein United States 9 117 0.3× 191 0.6× 36 0.2× 66 0.4× 39 0.3× 10 424
Mislen Bauer United States 10 143 0.4× 269 0.8× 84 0.5× 107 0.7× 26 0.2× 19 561
Karelle Bénistan France 10 133 0.3× 405 1.3× 145 0.8× 216 1.4× 150 1.3× 31 599
Luis A. Barrera Colombia 17 191 0.5× 603 1.9× 116 0.6× 278 1.8× 122 1.1× 27 830
Molly Stapleton United States 12 153 0.4× 407 1.3× 79 0.4× 187 1.2× 66 0.6× 19 600
Vũ Chí Dũng Vietnam 18 298 0.8× 729 2.3× 148 0.8× 319 2.1× 191 1.7× 38 1.1k
Spyros Batzios Greece 15 153 0.4× 149 0.5× 37 0.2× 62 0.4× 45 0.4× 42 609
Eriko Yasuda Japan 17 151 0.4× 613 1.9× 73 0.4× 284 1.8× 115 1.0× 33 816
Karen Tylee United Kingdom 16 104 0.3× 580 1.8× 77 0.4× 259 1.7× 107 1.0× 45 704

Countries citing papers authored by Shari Fallet

Since Specialization
Citations

This map shows the geographic impact of Shari Fallet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shari Fallet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shari Fallet more than expected).

Fields of papers citing papers by Shari Fallet

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shari Fallet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shari Fallet. The network helps show where Shari Fallet may publish in the future.

Co-authorship network of co-authors of Shari Fallet

This figure shows the co-authorship network connecting the top 25 collaborators of Shari Fallet. A scholar is included among the top collaborators of Shari Fallet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shari Fallet. Shari Fallet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Volck, Birgitte, Shari Fallet, Mark Thomas, et al.. (2020). AVR-RD-01 lentiviral gene therapy reduces Gb3 substrate in endothelial cells of renal peritubular capillaries in a previously untreated classic Fabry disease male patient. Molecular Genetics and Metabolism. 129(2). S156–S157. 1 indexed citations
2.
Waddington‐Cruz, Márcia, Hartmut Schmidt, Marc Botteman, et al.. (2019). Epidemiological and clinical characteristics of symptomatic hereditary transthyretin amyloid polyneuropathy: a global case series. Orphanet Journal of Rare Diseases. 14(1). 42 indexed citations
3.
Waddington‐Cruz, Márcia, Hartmut Schmidt, Marc Botteman, et al.. (2017). Epidemiological and clinical characteristics of persons with transthyretin hereditary amyloid polyneuropathy: a global synthesis of 532 cases. Amyloid. 24(sup1). 109–110. 8 indexed citations
4.
Schmidt, Hartmut, Márcia Waddington‐Cruz, Marc Botteman, et al.. (2017). Global epidemiology of transthyretin hereditary amyloid polyneuropathy: a systematic review. Amyloid. 24(sup1). 111–112. 12 indexed citations
5.
Schmidt, Hartmut, Márcia Waddington‐Cruz, Marc Botteman, et al.. (2017). Estimating the global prevalence of transthyretin familial amyloid polyneuropathy. Muscle & Nerve. 57(5). 829–837. 139 indexed citations
6.
Schmidt, Hartmut, Márcia Waddington‐Cruz, Marc Botteman, et al.. (2016). Global Prevalence Estimates of Transthyretin Familial Amyloid Polyneuropathy (ATTR-FAP): A Systematic Review and Projections. Value in Health. 19(7). A601–A601. 1 indexed citations
7.
Al‐Sannaa, Nouriya, Deborah Barbouth, Cyril Goizet, et al.. (2015). Early treatment with laronidase improves clinical outcomes in patients with attenuated MPS I: a retrospective case series analysis of nine sibships. Orphanet Journal of Rare Diseases. 10(1). 131–131. 60 indexed citations
8.
Al‐Sannaa, Nouriya, Deborah Barbouth, Cyril Goizet, et al.. (2015). Early treatment with laronidase improves clinical outcomes in patients with attenuated MPS I: Analysis of eight sibling pairs. Molecular Genetics and Metabolism. 114(2). S93–S94. 1 indexed citations
9.
Beck, Michael, Pamela Arn, Roberto Giugliani, et al.. (2014). The natural history of MPS I: global perspectives from the MPS I Registry. Genetics in Medicine. 16(10). 759–765. 118 indexed citations
10.
Arn, Pamela, Iain Bruce, J. E. Wraith, Helen Travers, & Shari Fallet. (2014). Airway-Related Symptoms and Surgeries in Patients With Mucopolysaccharidosis I. Annals of Otology Rhinology & Laryngology. 124(3). 198–205. 40 indexed citations
11.
Levy, Brynn, Peter Papenhausen, James Tepperberg, et al.. (2000). Prenatal molecular cytogenetic diagnosis of partial tetrasomy 10p due to neocentromere formation in an inversion duplication analphoid marker chromosome. Cytogenetic and Genome Research. 91(1-4). 165–170. 25 indexed citations
12.
Zaslav, Ann‐Leslie, et al.. (1999). Mosaicism with a normal cell line and an unbalanced structural rearrangement. American Journal of Medical Genetics. 82(1). 15–19. 15 indexed citations
13.
Zaslav, Ann‐Leslie, et al.. (1999). Mosaicism with a normal cell line and an unbalanced structural rearrangement. American Journal of Medical Genetics. 82(1). 15–19. 1 indexed citations
14.
Fallet, Shari, et al.. (1998). Prenatal diagnosis of low level trisomy 15 mosaicism: review of the literature. Clinical Genetics. 53(4). 286–292. 27 indexed citations
15.
Levanat, Sonja, et al.. (1996). A two-hit model for developmental defects in Gorlin syndrome. Nature Genetics. 12(1). 85–87. 147 indexed citations
16.
Koppel, Robert, et al.. (1996). Congenital vocal cord paralysis with possible autosomal recessive inheritance: Case report and review of the literature. American Journal of Medical Genetics. 64(3). 485–487. 10 indexed citations
17.
Ghidini, Alessandro, et al.. (1993). Prenatal detection of monosomy 21 mosaicism. Prenatal Diagnosis. 13(3). 163–169. 11 indexed citations
18.
Fallet, Shari, et al.. (1992). Enzyme Augmentation in Moderate to Life-Threatening Gaucher Disease. Pediatric Research. 31(5). 496–502. 81 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by K D MacDermot Breakdown of academic impact, for papers by Jason S. Weisstein Breakdown of academic impact, for papers by Mislen Bauer Breakdown of academic impact, for papers by Karelle Bénistan Breakdown of academic impact, for papers by Luis A. Barrera Breakdown of academic impact, for papers by Molly Stapleton Breakdown of academic impact, for papers by Vũ Chí Dũng Breakdown of academic impact, for papers by Spyros Batzios Breakdown of academic impact, for papers by Eriko Yasuda Breakdown of academic impact, for papers by Karen Tylee
Rankless by CCL
2026